RT @jdoeswijk: @Brandon_Beaber @Brandon_Beaber whats your opinion / experience on switching from gilenya/fingolimod to rituximab? I saw dif…
@Brandon_Beaber @Brandon_Beaber whats your opinion / experience on switching from gilenya/fingolimod to rituximab? I saw different articles / postings on it. i.e. https://t.co/2XcjaocL5q and https://t.co/ZLdW5CjQZS
RT @farmaciaclinico: Treatment with alemtuzumab or rituximab after fingolimod withdrawal in relapsing–remitting multiple sclerosis is effec…
RT @farmaciaclinico: Treatment with alemtuzumab or rituximab after fingolimod withdrawal in relapsing–remitting multiple sclerosis is effec…
RT @farmaciaclinico: Treatment with alemtuzumab or rituximab after fingolimod withdrawal in relapsing–remitting multiple sclerosis is effec…
Treatment with alemtuzumab or rituximab after fingolimod withdrawal in relapsing–remitting multiple sclerosis is effective and safe https://t.co/I35CUpZIoY
RT @CambridgeNeuro1: Treatment with alemtuzumab or rituximab after fingolimod withdrawal in relapsing-remitting multiple sclerosis is effec…
Treatment with alemtuzumab or rituximab after fingolimod withdrawal in relapsing-remitting multiple sclerosis is effective and safe. https://t.co/G05VyCbjfy #pubmed #feedly
RT @OhioHealthMS: Treatment with alemtuzumab or rituximab after fingolimod withdrawal in relapsing-remitting multiple sclerosis is effectiv…
RT @OhioHealthMS: Treatment with alemtuzumab or rituximab after fingolimod withdrawal in relapsing-remitting multiple sclerosis is effectiv…
RT @OhioHealthMS: Treatment with alemtuzumab or rituximab after fingolimod withdrawal in relapsing-remitting multiple sclerosis is effectiv…
RT @OhioHealthMS: Treatment with alemtuzumab or rituximab after fingolimod withdrawal in relapsing-remitting multiple sclerosis is effectiv…
RT @OhioHealthMS: Treatment with alemtuzumab or rituximab after fingolimod withdrawal in relapsing-remitting multiple sclerosis is effectiv…
Treatment with alemtuzumab or rituximab after fingolimod withdrawal in relapsing-remitting multiple sclerosis is effective and safe. - PubMed - NCBI https://t.co/EdcJumNhg8
Treatment with alemtuzumab or rituximab after fingolimod withdrawal in relapsing-remitting multiple sclerosis is effective and safe. - PubMed - NCBI https://t.co/8XEowZFKeB
Treatment with alemtuzumab or rituximab after fingolimod withdrawal in relapsing-remitting multiple sclerosis is effective and safe. https://t.co/5vZwgz8Vgo
RT @mirallesneuro: Treatment with alemtuzumab or rituximab after fingolimod withdrawal in relapsing–remitting multiple sclerosis is effecti…
RT @mirallesneuro: Treatment with alemtuzumab or rituximab after fingolimod withdrawal in relapsing–remitting multiple sclerosis is effecti…
RT @mirallesneuro: Treatment with alemtuzumab or rituximab after fingolimod withdrawal in relapsing–remitting multiple sclerosis is effecti…
RT @mirallesneuro: Treatment with alemtuzumab or rituximab after fingolimod withdrawal in relapsing–remitting multiple sclerosis is effecti…
Treatment with alemtuzumab or rituximab after fingolimod withdrawal in relapsing–remitting multiple sclerosis is effective and safe https://t.co/9uY0Rk4b0j doi: https://t.co/KE3gYg5G7W #MultipleSclerosis #esclerosismúltiple @UnicLaFe @HospitalLaFe @GVAclin